2009
DOI: 10.1186/1742-4690-6-45
|View full text |Cite
|
Sign up to set email alerts
|

Phenotypic and genotypic characterization of Human Immunodeficiency Virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China

Abstract: BackgroundHIV-1 CRF07_BC recombinant previously circulated mainly among the intravenous drug users (IDUs) in Xinjiang province of China and is currently spreading in the entire country. The aim of this study is to characterize the genotypic and phenotypic properties of HIV-1 CRF07_BC isolates in comparison with those of the subtype B' (Thailand B) which is prevalent in the former plasma donors (FPDs) in China.ResultsTwelve HIV-1 CRF07_BC variants were isolated from the blood of the HIV-1-infected IDUs in Xinji… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
21
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 32 publications
1
21
1
Order By: Relevance
“…Consistent with previous reports, 2.3~15.6% and 0~1.9% expressed CD4 and CXCR4 or CD4 and CCR5 respectively. The low expression of CCR5 co-receptor on HPCs may explain the limited infection efficacy, ~0.86% observed in our experiments, since it was reported [25] that the cell tropisms of primary isolates of subtype B/C from Chinese HIV-1 infected patients only used CCR5 as the co-receptor. While the expression of CD4, CCR5 and CXCR4 on HPCs enables these cells as potential targets for HIV-1 infection, however, CCR5 ligands, including MIP-1 , MIP-1 , and RANTES, as well as CXCR4 ligand SDF-1 secreted by CD34 + HPCs [26][27][28], could compete with HIV-1 and thereby block the entry of HIV-1 into HPCs.…”
Section: Disscussioncontrasting
confidence: 48%
“…Consistent with previous reports, 2.3~15.6% and 0~1.9% expressed CD4 and CXCR4 or CD4 and CCR5 respectively. The low expression of CCR5 co-receptor on HPCs may explain the limited infection efficacy, ~0.86% observed in our experiments, since it was reported [25] that the cell tropisms of primary isolates of subtype B/C from Chinese HIV-1 infected patients only used CCR5 as the co-receptor. While the expression of CD4, CCR5 and CXCR4 on HPCs enables these cells as potential targets for HIV-1 infection, however, CCR5 ligands, including MIP-1 , MIP-1 , and RANTES, as well as CXCR4 ligand SDF-1 secreted by CD34 + HPCs [26][27][28], could compete with HIV-1 and thereby block the entry of HIV-1 into HPCs.…”
Section: Disscussioncontrasting
confidence: 48%
“…The sources of HIV-1 SF33 and TZM-bl, as well as the methods used for their preservation and passage have been described previously [20,41]. The clinical isolates of HIV-1 subtypes B 0 , BC, and AE were obtained from treatment-naive patients and stored at our laboratory in Chinese Center for Disease Control and Prevention [46,47]. These viruses represent the predominant strains circulating in China from 2005 to 2008.…”
Section: Materials and Instrumentationmentioning
confidence: 99%
“…Median CD4 counts and plasma viral loads at the time of sampling were 378 cells/mm 3 (full range: 50–940 cells/mm 3 ) and 20,700 copies/ml (full range: <50–714,000 copies/ml), respectively (Table S1). Subjects became infected through sharing contaminated needles during drug use, and subjects were confirmed to be infected with CRF07_BC strain162526 (Table S1). The historical neutralization data of 103 subjects from the FPD cohort15 with over ten years’ infection time were used to compare with those generated in the IDU cohort.…”
Section: Methodsmentioning
confidence: 99%
“…Our laboratory previously studied the biological and virological characteristics25 and cytotoxic T lymphocyte (CTL) response pattern26 of CRF07_BC infection. However, the humoral response pattern during infection caused by this unique recombinant subtype has not yet been adequately investigated.…”
mentioning
confidence: 99%